two new therapies for advanced breast cancer

February 1996

Zeneca will be promoting two new therapies for advanced breast cancer...Zoladex (goserelin implant) and Arimidex (anastrozole).

Zoladex was already on the market for treating prostate cancer and endometriosis, but now it's also approved for metastatic breast cancer...in women who have NOT yet gone through menopause.

Zoladex works by suppressing estrogen production to post-menopausal levels...to reduce the growth of estrogen-responsive tumors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote